Frontotemporal dementia (FTD) is a distinct form of dementia characterized by progressive damage to the frontal and temporal lobes of the brain. Unlike Alzheimer's disease, which primarily affects memory, FTD typically manifests with changes in personality, behavior, and language skills. Individuals with FTD may exhibit socially inappropriate behavior, lack of empathy, and difficulty with language comprehension or expression. This condition often affects younger individuals compared to Alzheimer's, typically striking between the ages of 40 and 65. Diagnosis involves neurological exams, brain imaging, and sometimes genetic testing. Treatment focuses on managing symptoms, as there is currently no cure for FTD. Research into its causes and potential therapies continues, aiming to improve understanding and care for those affected by this challenging form of dementia.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States